glp 1 patient education Q&A: Long-term success of GLP-1 therapies hinges on more than just a prescription Ontario's Anesthesiologists | ICYMI: Recently,

Vomiting: Some individuals may experience vomiting, especially if the dosage is escalated too quickly

In CVOTs, liraglutide, semaglutide and dulaglutide demonstrated appreciable cardiovascular and renal protective effects, among which liraglutide had an appreciable effect on mitigating the risk of cardiovascular death [4], while semaglutide and dulaglutide conferred a risk reduction on non-fatal stroke [22, 23]

The comprehensive exploration of their benefits underscores their transformative potential in medicine, positioning them as a promising approach for addressing a wide array of health issues and paving the way for new research and clinical applications

J Biol Chem